Highlights
ASX: TLX       TELIX PHARMACEUTICALS LIMITED
Last Price Today's Change   Day's Range   Trading Volume
1.66   0.00 (0.00%)  0.00 - 0.00  0

Overview

 
Avg Volume (4 weeks):586,046
4 Weeks Range:1.555 - 1.95
4 Weeks Price Volatility (%):
85.13%
52 Weeks Range:0.54 - 1.95
52 Weeks Price Volatility (%):
85.13%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company. The Company is focused on development and commercialization of diagnostic and therapeutic products based on radiopharmaceuticals, or molecularly-targeted radiation (MTR). MTR is a novel therapeutic approach that selectively delivers radiation to cells that exhibit certain molecular profiles or targets that may be indicative of cancer. The Company's MTR products such as TLX-250 diagnosis and treatment of renal (kidney), TLX-591 treatment of metastatic castrate-resistant prostate cancer, and TLX-101 treatment of glioblastoma (brain cancer).

  Be the first to like this.
 


 

4300 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AAC 1.1350.00 
 TPO 0.090.00 
 NCMLOF 4.230.00 
 AAJ 0.0030.00 
 WPLKOV 4.350.00 
 AAR 0.0930.00 
 VMX 0.2950.00 
 AAU 0.0090.00 
 MPL 3.250.00 
 ABC 3.480.00 
Partners & Brokers